[DPHARMA] QoQ Annualized Quarter Result on 30-Sep-2012 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
23-Nov-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
30-Sep-2012 [#3]
Profit Trend
QoQ- -1.7%
YoY- -1.77%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Revenue 151,652 151,348 135,310 133,242 140,824 144,228 138,132 6.42%
PBT 43,926 35,824 35,298 35,064 35,812 35,476 34,728 16.97%
Tax -9,150 -9,028 -9,284 -8,374 -8,662 -8,644 -8,023 9.16%
NP 34,776 26,796 26,014 26,689 27,150 26,832 26,705 19.26%
-
NP to SH 34,776 26,796 26,014 26,689 27,150 26,832 26,705 19.26%
-
Tax Rate 20.83% 25.20% 26.30% 23.88% 24.19% 24.37% 23.10% -
Total Cost 116,876 124,552 109,296 106,553 113,674 117,396 111,427 3.23%
-
Net Worth 187,340 176,143 169,354 167,965 162,400 170,824 163,783 9.38%
Dividend
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Div 11,101 - 19,434 - 9,716 - 24,983 -41.79%
Div Payout % 31.92% - 74.71% - 35.79% - 93.56% -
Equity
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Net Worth 187,340 176,143 169,354 167,965 162,400 170,824 163,783 9.38%
NOSH 138,770 138,695 138,815 138,814 138,803 138,881 138,799 -0.01%
Ratio Analysis
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
NP Margin 22.93% 17.70% 19.23% 20.03% 19.28% 18.60% 19.33% -
ROE 18.56% 15.21% 15.36% 15.89% 16.72% 15.71% 16.31% -
Per Share
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
RPS 109.28 109.12 97.47 95.99 101.46 103.85 99.52 6.44%
EPS 25.06 19.32 18.74 19.23 19.56 19.32 19.24 19.28%
DPS 8.00 0.00 14.00 0.00 7.00 0.00 18.00 -41.79%
NAPS 1.35 1.27 1.22 1.21 1.17 1.23 1.18 9.39%
Adjusted Per Share Value based on latest NOSH - 138,836
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
RPS 15.75 15.72 14.06 13.84 14.63 14.98 14.35 6.40%
EPS 3.61 2.78 2.70 2.77 2.82 2.79 2.77 19.33%
DPS 1.15 0.00 2.02 0.00 1.01 0.00 2.60 -41.97%
NAPS 0.1946 0.183 0.1759 0.1745 0.1687 0.1775 0.1701 9.39%
Price Multiplier on Financial Quarter End Date
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Date 28/06/13 29/03/13 31/12/12 28/09/12 29/06/12 30/03/12 30/12/11 -
Price 2.38 2.23 2.13 2.36 2.23 2.40 2.02 -
P/RPS 2.18 2.04 2.19 2.46 2.20 2.31 2.03 4.87%
P/EPS 9.50 11.54 11.37 12.27 11.40 12.42 10.50 -6.46%
EY 10.53 8.66 8.80 8.15 8.77 8.05 9.52 6.95%
DY 3.36 0.00 6.57 0.00 3.14 0.00 8.91 -47.83%
P/NAPS 1.76 1.76 1.75 1.95 1.91 1.95 1.71 1.94%
Price Multiplier on Announcement Date
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Date 28/08/13 27/05/13 25/02/13 23/11/12 16/08/12 17/05/12 22/02/12 -
Price 2.44 2.51 2.17 2.28 2.38 2.38 2.12 -
P/RPS 2.23 2.30 2.23 2.38 2.35 2.29 2.13 3.10%
P/EPS 9.74 12.99 11.58 11.86 12.17 12.32 11.02 -7.90%
EY 10.27 7.70 8.64 8.43 8.22 8.12 9.08 8.56%
DY 3.28 0.00 6.45 0.00 2.94 0.00 8.49 -46.98%
P/NAPS 1.81 1.98 1.78 1.88 2.03 1.93 1.80 0.37%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment